Standout Papers
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group (2009)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging (2017)
Immediate Impact
2 by Nobel laureates 34 from Science/Nature 67 standout
Citing Papers
A body–brain circuit that regulates body inflammatory responses
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Rudolf Arnold being referenced
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
2016
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rudolf Arnold | 4460 | 1594 | 3886 | 2999 | 111 | 7.1k | |
| Ulrich Knigge | 5512 | 1007 | 5056 | 3702 | 220 | 9.1k | |
| H. Ahlman | 1998 | 1030 | 1416 | 1378 | 158 | 4.6k | |
| R. Arnold | 1773 | 2324 | 1363 | 844 | 174 | 5.5k | |
| Håkan Ahlman | 2107 | 1063 | 1673 | 1443 | 112 | 4.2k | |
| Jerome M. Feldman | 1646 | 1272 | 1006 | 1356 | 188 | 4.3k | |
| Beata Kos‐Kudła | 2935 | 408 | 2515 | 1610 | 235 | 4.7k | |
| T. J. Visser | 1850 | 245 | 1486 | 1069 | 103 | 5.6k | |
| Coimbatore B. Srikant | 2147 | 846 | 789 | 589 | 73 | 4.6k | |
| F. Stadil | 1231 | 2237 | 602 | 241 | 124 | 4.5k | |
| Jens F. Rehfeld | 953 | 1067 | 588 | 316 | 120 | 3.7k |
All Works
Loading papers...